Karin Magnussen1, Steen Ladelund2. 1. Department of Clinical Immunology and Blood Centre, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark. 2. Clinical Research Centre, Copenhagen University Hospital, Hvidovre, Denmark.
Abstract
BACKGROUND: Iron deficiency and blood donors with low hemoglobin (Hb) concentration are well-known challenges in any blood bank setting. In the Capital Region of Denmark, a new approach was adopted that centralized measurement of Hb, initiated ferritin (F) measurement, and established a center for donor Hb and iron. An algorithm was created based on Hb and F levels, which drove decisions on outreach by the donor Hb and iron resource team to the donor, including whether to provide iron supplementation or, on rare occasions, a referral to the donor's general practitioner. STUDY DESIGN AND METHODS: The change in Hb for repeat donors was followed during the first 2 years of the intervention strategy, which included measurements of F and offering intermittent iron supplementation to some of the donors. RESULTS: In 2 years, 62,663 blood donors donated 193,288 units of blood and 318 donors gave 754 complete blood count blood samples. Over time in the repeat donors, the Hb increased from 15.39 to 15.60 g/dL and 13.85 to 14.06 g/dL in male and female donors, respectively, and the proportion of donors with low Hb decreased from 0.9% to 0.3% and 3.9% to 2.7% for the male and female donors, respectively. CONCLUSION: The program with goal-directed iron supplementation only to those that would benefit has led to an increase in Hb concentration and a reduction in the proportion of donors with low Hb concentration.
BACKGROUND:Iron deficiency and blood donors with low hemoglobin (Hb) concentration are well-known challenges in any blood bank setting. In the Capital Region of Denmark, a new approach was adopted that centralized measurement of Hb, initiated ferritin (F) measurement, and established a center for donor Hb and iron. An algorithm was created based on Hb and F levels, which drove decisions on outreach by the donor Hb and iron resource team to the donor, including whether to provide iron supplementation or, on rare occasions, a referral to the donor's general practitioner. STUDY DESIGN AND METHODS: The change in Hb for repeat donors was followed during the first 2 years of the intervention strategy, which included measurements of F and offering intermittent iron supplementation to some of the donors. RESULTS: In 2 years, 62,663 blood donors donated 193,288 units of blood and 318 donors gave 754 complete blood count blood samples. Over time in the repeat donors, the Hb increased from 15.39 to 15.60 g/dL and 13.85 to 14.06 g/dL in male and female donors, respectively, and the proportion of donors with low Hb decreased from 0.9% to 0.3% and 3.9% to 2.7% for the male and female donors, respectively. CONCLUSION: The program with goal-directed iron supplementation only to those that would benefit has led to an increase in Hb concentration and a reduction in the proportion of donors with low Hb concentration.
Authors: Ritchard G Cable; Rebecca J Birch; Bryan R Spencer; David J Wright; Walter Bialkowski; Joseph E Kiss; Jorge Rios; Barbara J Bryant; Alan E Mast Journal: Transfusion Date: 2017-07-13 Impact factor: 3.157
Authors: Tomislav Vuk; Karin Magnussen; Wim De Kort; Gilles Folléa; Giancarlo M Liumbruno; Harald Schennach; Giovani Vandewalle; Veerle Compernolle; Natalia Masharova; Georgia Karakatsiani; Isabella Argyrou; Vít Řeháček; Gulara Khanirzajeva; Johanna Castrén; Bruno Danic; Rachid Djoudi; Geneviève Woimant; Markus M Mueller; Constantina Politis; Stefania Vaglio; Anita Daugavvanaga; Edita Vilutytė; Jean-Claude Faber; Denise Borg-Aquilina; Peter Van Den Burg; Arlinke Bokhorst; Ryszard Pogłód; Jolanta Antoniewicz-Papis; Mario Muon; Olivia L Burta; Jana Rosochová; Polonca Mali; Miguel A Vesga; Karin Schneider; Rut Norda; Nicky Anderson Journal: Blood Transfus Date: 2016-09-07 Impact factor: 3.443
Authors: Muriel Lobier; Johanna Castrén; Pia Niittymäki; Elina Palokangas; Jukka Partanen; Mikko Arvas Journal: PLoS One Date: 2019-08-13 Impact factor: 3.240
Authors: Steven Bell; Michael Sweeting; Anna Ramond; Ryan Chung; Stephen Kaptoge; Matthew Walker; Thomas Bolton; Jennifer Sambrook; Carmel Moore; Amy McMahon; Sarah Fahle; Donna Cullen; Susan Mehenny; Angela M Wood; Jane Armitage; Willem H Ouwehand; Gail Miflin; David J Roberts; John Danesh; Emanuele Di Angelantonio Journal: Transfus Med Date: 2020-12-20 Impact factor: 2.019
Authors: Stephen Kaptoge; Emanuele Di Angelantonio; Carmel Moore; Matthew Walker; Jane Armitage; Willem H Ouwehand; David J Roberts; John Danesh; Simon G Thompson Journal: Lancet Haematol Date: 2019-08-02 Impact factor: 30.153
Authors: Maike G Sweegers; Saurabh Zalpuri; Franke A Quee; Elisabeth M J Huis In 't Veld; Femmeke J Prinsze; Emiel O Hoogendijk; Jos W R Twisk; Anton W M van Weert; Wim L A M de Kort; Katja van den Hurk Journal: Trials Date: 2020-10-01 Impact factor: 2.279